UNIGE document Scientific Article
previous document  unige:111247  next document
add to browser collection

Pneumologie : asthme, BPCO et syndrome d’apnées du sommeil

Chappuis-Gisin, Émilie
Published in Revue médicale suisse. 2018, vol. 14, no. 588-589, p. 85-89
Abstract Among the novelties described in the management of pulmonary disorders during the year 2017, we chose to describe three. First, the indication for inhaled glucocorticosteroids (ICS) in COPD has been revisited, because of their relationship with an increased occurence of pneumonia : ICS are now recommended only in severe COPD (GOLD D) with frequent exacerbations as second line treatment. Secondly, azithromycine has shown very promising results in poorly controlled severe asthma, with a significant impact on symptoms and exacerbations. Finally, despite the association between sleep apnea syndrome and cardiovascular morbidity, the prescription of CPAP in asymptomatic individuals as primary or secondary prevention is not supported by the recent literature.
PMID: 29337458
Full text
Article (Published version) (155 Kb) - public document Free access
Research group Groupe Gasche-Soccal Paola (958)
(ISO format)
DUXBURY, Béatrice Jane et al. Pneumologie : asthme, BPCO et syndrome d’apnées du sommeil. In: Revue médicale suisse, 2018, vol. 14, n° 588-589, p. 85-89. https://archive-ouverte.unige.ch/unige:111247

289 hits



Deposited on : 2018-11-21

Export document
Format :
Citation style :